R

Revolution Medicines

Clinical-stage oncology company developing RAS inhibitors

Human Resources Business Partner

HR Generalist & Employee RelationsConfirmed live in the last 24 hours
Full-timeTokyo, JapanNo salary listedHybrid

About the Job

Requirements

  • A bachelor's degree in human resources, business administration, or a related field, or equivalent practical experience.
  • A minimum of six years of progressive human resources business partner or generalist experience.
  • Experience supporting employees and managers in Japan, with strong knowledge of Japanese employment law and human resources practices.
  • Native-level Japanese and professional business-level English proficiency, with strong written and verbal communication skills in both languages.
  • Experience with workforce planning, performance management, talent management, employee relations, and organizational change.
  • Experience leading employees, projects, or broad workstreams with accountability for execution and results.
  • Sound judgment, discretion, and the ability to resolve complex or sensitive people matters.
  • Strong analytical, consultative, and influencing skills, with the ability to use data and business context to make practical recommendations.
  • Ability to work effectively across cultures, functions, and levels in a fast-paced, matrixed environment.

Responsibilities

  • Develop an understanding of Japan business priorities and translate them into workforce, talent, organization, and change plans.
  • Advise business and people managers on day-to-day people and organization matters.
  • Support annual performance, compensation and promotion, talent succession, and employee-engagement surveys for Japan, partnering with the human resources center of expertise to ensure quality, consistency, and timely execution.
  • Coach managers on leadership, performance management, employee development, team dynamics, and organizational change.
  • Partner with regional and global human resources teams to assess, evolve, and improve local processes, clarifying roles and responsibilities with appropriate localization.
  • Act as a trusted point of contact for employees and managers.
  • Manage employee relations matters and support workplace investigations with human resources leadership and Legal, in accordance with Japanese law and company policy.
  • Lead Japan implementation of global and regional human resources programs and policies, including stakeholder communication, manager enablement, and adoption.
  • Design, implement, and coordinate the end-to-end people experience from recruitment and onboarding through employment changes and offboarding, partnering with Talent Acquisition, Human Resources Operations, Total Rewards, and relevant business functions to ensure clear ownership, smooth handoffs, and consistent execution.
  • Use people data and employee feedback to identify trends, resolve issues, and recommend practical improvements.
  • Set priorities, coordinate work, and coach assigned human resources team members while supporting an inclusive and accountable team culture.
  • Monitor employment-law developments, identify people-related risks, and ensure compliant local practices in partnership with Legal and human resources leaders.
  • Model the company's core values and promote integrity, collaboration, inclusion, innovation, and commitment to patients.

Desired Qualifications

  • Experience in biotechnology, pharmaceuticals, life sciences, or another regulated technical environment.
  • Experience supporting a growing Japan organization within a global company.
  • Experience implementing global human resources programs and adapting them to local requirements.
  • Experience with Workday or a comparable enterprise human resources platform.

About the Company

Revolution Medicines

Clinical-stage oncology company developing RAS inhibitors

Revolution Medicines develops precision oncology drugs focused on cancers driven by RAS mutations. Its RAS(ON) inhibitors are small molecules that bind the active form of RAS to block cancer signaling, with candidates like Daraxonrasib (RMC-6236), Elironrasib (RMC-6291), and Zoldonrasib (RMC-9805) advancing in global Phase 3 trials. The company funds its research through collaborations, royalties, and upfront funding, and has not yet marketed a product. Its goal is to bring effective RAS-targeted therapies to patients and advance multiple candidates through late-stage trials toward approval, supported by strong cash reserves.

Company size
1,001-5,000
Company stage
IPO
Headquarters
Redwood City, CA
Founded
2014

Recently Posted Jobs

Explore more opportunities at Revolution Medicines

See more jobs